Hae-Young Lopilly Park1, Bo-Een Hwang1, Hye-Young Shin2, Chan Kee Park3. 1. Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea; Seoul St Mary's Hospital, Seoul, South Korea. 2. Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea; Uijeongbu St Mary's Hospital, Uijeongbu, South Korea. 3. Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea; Seoul St Mary's Hospital, Seoul, South Korea. Electronic address: ckpark@catholic.ac.kr.
Abstract
PURPOSE: To investigate characteristics related to the presence of parafoveal scotoma on Humphrey 10-2 visual field (VF) in early glaucoma patients. DESIGN: Prospective, cross-sectional study. METHODS: participants: Ninety-one eyes from 91 patients with glaucomatous optic neuropathy were prospectively tested with a 10-2 VF test. OBSERVATION PROCEDURES: Glaucoma patients were classified into eyes with or without parafoveal scotoma on 10-2 VF based on pattern deviation plot. The central 10 degree region of Humphrey 24-2 VF test comprised 12 points and any abnormal VF points depressed <5%, <2%, <1%, or <0.5% from the normal database on pattern deviation plot were analyzed. Various factors related to the presence of parafoveal scotoma on 10-2 VF were analyzed. MAIN OUTCOME MEASURES: Abnormal 24-2 VF points, macular ganglion cell-inner plexiform layer thickness. RESULTS: The presence of abnormal 24-2 VF points <0.5% was significantly different between eyes with and without parafoveal scotoma on 10-2 VF (P < .01). The minimum macular ganglion cell-inner plexiform layer thickness (P = .04), any central 12 points depressed <0.5% on 24-2 VF (P < .01), and any central 12 points depressed <5% on 24-2 VF that spatially corresponds to macular ganglion cell-inner plexiform layer thinning (P < 0.01) were related factors to the presence of parafoveal scotoma on 10-2 VF. CONCLUSIONS: Glaucomatous eyes with any abnormal 24-2 VF points on the central 10 degree region that are depressed <0.5% or <5% that correlates to macular ganglion cell-inner plexiform layer thinning should receive attention and be further evaluated with a 10-2 VF test.
PURPOSE: To investigate characteristics related to the presence of parafoveal scotoma on Humphrey 10-2 visual field (VF) in early glaucomapatients. DESIGN: Prospective, cross-sectional study. METHODS:participants: Ninety-one eyes from 91 patients with glaucomatous optic neuropathy were prospectively tested with a 10-2 VF test. OBSERVATION PROCEDURES: Glaucomapatients were classified into eyes with or without parafoveal scotoma on 10-2 VF based on pattern deviation plot. The central 10 degree region of Humphrey 24-2 VF test comprised 12 points and any abnormal VF points depressed <5%, <2%, <1%, or <0.5% from the normal database on pattern deviation plot were analyzed. Various factors related to the presence of parafoveal scotoma on 10-2 VF were analyzed. MAIN OUTCOME MEASURES: Abnormal 24-2 VF points, macular ganglion cell-inner plexiform layer thickness. RESULTS: The presence of abnormal 24-2 VF points <0.5% was significantly different between eyes with and without parafoveal scotoma on 10-2 VF (P < .01). The minimum macular ganglion cell-inner plexiform layer thickness (P = .04), any central 12 points depressed <0.5% on 24-2 VF (P < .01), and any central 12 points depressed <5% on 24-2 VF that spatially corresponds to macular ganglion cell-inner plexiform layer thinning (P < 0.01) were related factors to the presence of parafoveal scotoma on 10-2 VF. CONCLUSIONS:Glaucomatous eyes with any abnormal 24-2 VF points on the central 10 degree region that are depressed <0.5% or <5% that correlates to macular ganglion cell-inner plexiform layer thinning should receive attention and be further evaluated with a 10-2 VF test.
Authors: Carlos Gustavo De Moraes; Ashley Sun; Ravivarn Jarukasetphon; Rashmi Rajshekhar; Lynn Shi; Dana M Blumberg; Jeffrey M Liebmann; Robert Ritch; Donald C Hood Journal: JAMA Ophthalmol Date: 2019-02-01 Impact factor: 7.389
Authors: Donald C Hood; Sol La Bruna; Emmanouil Tsamis; Ari Leshno; Bruna Melchior; Jennifer Grossman; Jeffrey M Liebmann; Carlos Gustavo De Moraes Journal: Ophthalmol Glaucoma Date: 2022-03-28
Authors: Aakriti G Shukla; Portia E Sirinek; C Gustavo De Moraes; Dana M Blumberg; George A Cioffi; Alon Skaat; Christopher A Girkin; Robert N Weinreb; Linda M Zangwill; Donald C Hood; Jeffrey M Liebmann Journal: J Glaucoma Date: 2020-06 Impact factor: 2.503
Authors: C Gustavo De Moraes; Donald C Hood; Abinaya Thenappan; Christopher A Girkin; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill; Jeffrey M Liebmann Journal: Ophthalmology Date: 2017-05-24 Impact factor: 12.079
Authors: Donald C Hood; Abinaya A Thenappan; Emmanouil Tsamis; Jeffrey M Liebmann; C Gustavo De Moraes Journal: Am J Ophthalmol Date: 2020-08-07 Impact factor: 5.258
Authors: Eren Ekici; Sasan Moghimi; Huiyuan Hou; James Proudfoot; Linda M Zangwill; Jiun L Do; Won Hyuk Oh; Alireza Kamalipour; Jeffrey M Liebmann; Carlos Gustavo De Moraes; Christopher A Girkin; Nevin El-Nimri; Robert N Weinreb Journal: Am J Ophthalmol Date: 2020-10-29 Impact factor: 5.258